ACCPL
Start SIP
Invest Now
Start SIP in ACCPL
Performance
- Low
- ₹64
- High
- ₹67
- 52 Week Low
- ₹54
- 52 Week High
- ₹103
- Open Price₹67
- Previous Close₹67
- Volume22,800
- 50 DMA₹77.20
- 100 DMA₹74.59
- 200 DMA-
Investment Returns
- Over 1 Month -28.87%
- Over 3 Month + 15.82%
- Over 6 Month -1%
- Over 1 Year -36.58%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 10.5
- PEG Ratio
- -
- Market Cap Cr
- 71
- P/B Ratio
- 1.5
- Average True Range
- 3.75
- EPS
- 6.11
- Dividend Yield
- 0
- MACD Signal
- -3.75
- RSI
- 30.22
- MFI
- 14.85
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
Current Price
₹64.05
-3.25
(-4.83%)
- Bearish Moving Average 14
- Bullish Moving Average 0
- 20 Day
- ₹74.67
- 50 Day
- ₹77.20
- 100 Day
- ₹74.59
- 200 Day
- -
Resistance and Support
65.02
- R3 69.03
- R2 68.02
- R1 66.03
- S1 63.03
- S2 62.02
- S3 60.03
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-06-10 | Audited Results & Others | To consider Other business matters. |
Accretion Pharmaceuticals F&O
About Accretion Pharmaceuticals
- NSE Symbol
- ACCPL
- BSE Symbol
- Managing Director
- Mr. Vivek Ashok Kumar Patel
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹64 As on 24 January, 2026 | 04:28
The Market Cap of Accretion Pharmaceuticals is ₹71.2 Cr As on 24 January, 2026 | 04:28
The P/E ratio of Accretion Pharmaceuticals is 10.5 As on 24 January, 2026 | 04:28
The PB ratio of Accretion Pharmaceuticals is 1.5 As on 24 January, 2026 | 04:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.